skip to main content

Genetic Counselling Empowers Parents of Children with Intellectual Disabilities : A Fragile X Syndrome Perspective

1Genetic Counseling, Master of Biomedical Sciences, Yarsi University, Jakarta, Indonesia, Indonesia

2Department of Psychology, Yarsi University, Jakarta, Indonesia, Indonesia

3Department of Genomic/Genetic Research Center, Yarsi University, Jakarta, Indonesia, Indonesia

Received: 10 Feb 2025; Revised: 28 Apr 2025; Accepted: 28 Apr 2025; Available online: 30 Apr 2025; Published: 30 Apr 2025.
Open Access Copyright (c) 2025 Journal of Biomedicine and Translational Research
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Citation Format:
Abstract
Background: Intellectual disabilities (ID) profoundly affect individuals and their families, leading to financial strain, emotional distress, and limited access to healthcare and education. Fragile X Syndrome (FXS), the most common inherited cause of ID, remains largely underdiagnosed in Indonesia due to limited awareness and resources.
Objective: This study aimed to assess the impact of genetic counselling on parental empowerment.
Methods: This pre-experimental study employed a before and after counselling. A total of 238 parents of children with ID from four special schools in Jakarta participated. Data were collected using the Genetic Counselling Outcome Scale-24 (GCOS-24), which assesses empowerment. Purposive sampling was applied, and data were analysed using paired t-tests and one-way ANOVA.
Results: The mean GCOS-24 score increased significantly from 106.79 (SD = 16.36) before counselling to 125.11 (SD = 15.42) after counselling (p < 0.001). Only 27.3% of parents were aware of genetic disorders, reflecting their limited baseline knowledge. A one-way ANOVA analysis showed a statistically significant difference in GCOS-24 score improvements based on parental education level (F=4.035, p=0.008) with parents with primary school education showing the greatest improvement compared to those with high school (p < 0.05).
Conclusions: Genetic counselling significantly enhanced parent empowerment, as evidenced by increased GCOS-24 scores. These findings emphasize the importance of expanding genetic counselling services and educational initiatives in Indonesia to improve awareness and support for families managing ID.

Note: This article has supplementary file(s).

Fulltext |  Research Instrument
Cover Letter to Editor
Subject
Type Research Instrument
  Download (18KB)    Indexing metadata
 Research Instrument
Conflict of Interest and CTA
Subject
Type Research Instrument
  Download (78KB)    Indexing metadata
 Research Instrument
Letter to the Editor
Subject
Type Research Instrument
  Download (52KB)    Indexing metadata
Keywords: Fragile X Syndrome ; genetic counselling ; intellectual disability ; parental empowerment ; empowerment

Article Metrics:

  1. Maia N, Nabais Sá MJ, Melo-Pires M, de Brouwer APM, Jorge P. Intellectual disability genomics: current state, pitfalls and future challenges. Vol. 22, BMC Genomics. BioMed Central Ltd; 2021. DOI: 10.1186/s12864-021-08227-4
  2. Sihombing NRB, Cai S, Wong DPW, Guan M, Chong SSC, Faradz SMH, et al. Repeat expansion and methylation-sensitive triplet-primed polymerase chain reaction for fragile X mental retardation 1 gene screening in institutionalised intellectually disabled individuals. Singapore Med J. 2021 Mar 1;62(3):143–8. DOI: 10.11622/smedj.2020009
  3. Sihombing NRB, Winarni TI, Utari A, Bokhoven H Van, Hagerman RJ, Faradz SMH. Surveillance and prevalence of fragile X syndrome in Indonesia. Vol. 10, Intractable and Rare Diseases Research. International Advancement Center for Medicine and Health Research Co., Ltd.; 2021. p. 11–6. DOI: 10.5582/irdr.2020.03101
  4. Soemantri A, Lam-Po-Tang PRL, Wright F, Lindeman R, Purvis-Smith3 S. Fragile X Mental Retardation t7 Fragile X Mental Retardation in an Indonesian Family. Vol. 4. DOI: https://doi.org/10.13181/mji.v4i1.885
  5. Patch C, Middleton A. Genetic counselling in the era of genomic medicine. Vol. 126, British Medical Bulletin. Oxford University Press; 2018. p. 27–36. DOI: 10.1093/bmb/ldy008
  6. Schalock RL, Luckasson R, Tassé MJ. An overview of intellectual disability: Definition, diagnosis, classification, and systems of supports (12th ed.). Vol. 126, American Journal on Intellectual and Developmental Disabilities. American Association on Mental Retardation; 2021. p. 439–42. https://doi.org/10.1352/1944-7558-126.6.439
  7. Mundhofir FE. Prevalence of fragile X syndrome in males and females in Indonesia. World J Med Genet. 2012;2(3):15. doi: 10.5496/wjmg.v2.i3.15
  8. Fazna A, Hagerman RJ. Prevalence of fragile X syndrome in South Asia, and importance of diagnosis. Medical Review. Walter de Gruyter GmbH; 2024. DOI: 10.1515/mr-2024-0060
  9. Kamga KK, Nguefack S, Minka K, Tingang EW, Esterhuizen A, Munung SN, et al. Cascade testing for Fragile X syndrome in a rural setting in cameroon (Sub-Saharan Africa). Genes (Basel). 2020 Feb 1;11(2). DOI: 10.3390/genes11020136
  10. Jansen S, Vissers LELM, de Vries BBA. The Genetics of Intellectual Disability. Vol. 13, Brain Sciences. MDPI; 2023. https://doi.org/10.3390/brainsci13020231
  11. Faradz SM, Winarni TI. Focal areas of a high rate of fragile X in Indonesia: a long term follow up. Journal of Biomedicine and Translational Research. 2019 Dec 31;5(2):67–8
  12. Gusrianti E, Winarni TI, Faradz SM. Factors Affecting Parents’ Acceptance towards Children with Familial Intellectual Disability (ID). Journal of Biomedicine and Translational Research. 2018 Dec 31;4(2):45. https://doi.org/10.14710/jbtr.v4i2.3659
  13. Corbo A, Tzeng JP, Scott S, Cheves E, Cope H, Peay H. Parent perspectives following newborn screening resulting in diagnoses of fragile X syndrome or fragile X premutation. Res Dev Disabil. 2024 May 1;148
  14. Costal Tirado A, McDermott AM, Thomas C, Ferrick D, Harris J, Edwards A, et al. Using Patient-Reported Outcome Measures for Quality Improvement in Clinical Genetics: an Exploratory Study. J Genet Couns. 2017 Oct 1;26(5):1017–28. https://doi.org/10.1016/j.ridd.2024.104719
  15. Yuen J, Lee SY, Courtney E, Lim J, Soh H, Li ST, et al. Evaluating empowerment in genetic counselling using patient-reported outcomes. Clin Genet. 2020 Feb 1;97(2):246–56. DOI: 10.1111/cge.13646
  16. Palmer CGS, McConkie-Rosell A, Holm IA, LeBlanc K, Sinsheimer JS, Briere LC, et al. Understanding Adult Participant and Parent Empowerment Prior to Evaluation in the Undiagnosed Diseases Network. J Genet Couns. 2018 Sep 1;27(5):1087–101. DOI: 10.1007/s10897-018-0228-6
  17. Mcallister M, Wood A, Dunn G, Shiloh S, Todd C. The Genetic Counselling Outcome Scale: A new patient-reported outcome measure for clinical genetics services. Clin Genet. 2011 May;79(5):413–24. doi: 10.1111/j.1399-0004.2011.01636.x
  18. Thomas C, McAllister M. Establishing the minimum clinically important difference for the Genetic Counselling Outcome Scale (GCOS-24). J Genet Couns. 2019 Oct 1;28(5):1003–10. DOI: 10.1002/jgc4.1152
  19. Fitrianingrum I, Ediati A, Winarni TI, Faradz SM. The Evaluation of Parental Acceptance Towards Children with Sex Chromosomal Disorders of Sex Development Using A Mixed-Method. Journal of Biomedicine and Translational Research. 2021 Apr 30;7(1):14–21. DOI: 10.14710/jbtr.v7i1.10710
  20. Splinter K, Adams DR, Bacino CA, Bellen HJ, Bernstein JA, Cheatle-Jarvela AM, et al. Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease. New England Journal of Medicine. 2018 Nov 29;379(22):2131–9. DOI: 10.1056/NEJMoa1714458

Last update:

No citation recorded.

Last update:

No citation recorded.